Early research (Phase 1)UnknownNCT02134392What this trial is testingFecal Transplant for Pediatric Patients Who Have Recurrent C-diff InfectionWho this might be right forClostridium Difficile Jonathan Gisser 15
Large-scale testing (Phase 3)Study completedNCT03123939What this trial is testingPhase III B in Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 69
Testing effectiveness (Phase 2)Ended earlyNCT05255601What this trial is testingEvaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin LymphomaWho this might be right forLymphoma, Non-HodgkinHodgkin Disease Bristol-Myers Squibb 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03573700What this trial is testingEvaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, Refractory St. Jude Children's Research Hospital 24
Testing effectiveness (Phase 2)Study completedNCT01159275What this trial is testingLopinavir (LPV) Dose ReductionWho this might be right forHIV-1 Infections The HIV Netherlands Australia Thailand Research Collaboration 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04954001What this trial is testingStudy to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1Who this might be right forNeurofibromatosis 1Plexiform NeurofibromaNF1 Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 160
Testing effectiveness (Phase 2)Looking for participantsNCT04959903What this trial is testingSafety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCTWho this might be right forHematological Malignancies Smart Immune SAS 36
Not applicableLooking for participantsNCT05535361What this trial is testingA Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel SyndromeWho this might be right forShort Bowel Syndrome Eclipse Regenesis, Inc. 40
Not applicableStudy completedNCT03739372What this trial is testingClinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaWho this might be right forGliomaGlioma of BrainCancer+5 more University of California, San Francisco 44
Testing effectiveness (Phase 2)Ended earlyNCT04530487What this trial is testingDonor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young AdultsWho this might be right forDesmoplastic Small Round Cell TumorEwing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Desmoplastic Small Round Cell Tumor+9 more M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07206849What this trial is testingStudy of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)Who this might be right forHigh Grade Glioma (HGG) of the Brain With BRAF AberrationHigh Grade Glioma (III or IV)Diffuse Intrinsic Pontine Glioma+4 more Nationwide Children's Hospital 79
Testing effectiveness (Phase 2)Looking for participantsNCT06458036What this trial is testingSelpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)Who this might be right forDifferentiated Thyroid CancerPediatric CancerCancer+1 more Children's Hospital of Philadelphia 13
Early research (Phase 1)Not Yet RecruitingNCT06507904What this trial is testingLearn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy AdultsWho this might be right forHealthy Pfizer 52
Large-scale testing (Phase 3)Study completedNCT06548100What this trial is testingThe Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)Who this might be right forGeneralized Lipodystrophy Regeneron Pharmaceuticals 9
Not applicableStudy completedNCT00502177What this trial is testingQuality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With CisplatinWho this might be right forPeritoneal Neoplasms M.D. Anderson Cancer Center 48
Early research (Phase 1)Not Yet RecruitingNCT07799571What this trial is testingBuprenorphine for the Management of Pain in Children With Sickle Cell DiseaseWho this might be right forSickle Cell Disease (SCD)Sickle Cell Disease Vaso-occlusive CrisisSickle Cell Anemia Crisis+4 more Natasha Archer 25
Testing effectiveness (Phase 2)Ended earlyNCT04029688What this trial is testingA Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid TumorsWho this might be right forAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Neuroblastoma+1 more Hoffmann-La Roche 38
Early research (Phase 1)Active Not RecruitingNCT04898894What this trial is testingStudy of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forAcute Leukemia of Ambiguous Lineage in RelapseAcute Myeloid Leukemia, in RelapseRefractory Acute Leukemia of Ambiguous Lineage+1 more St. Jude Children's Research Hospital 37
Not applicableStudy completedNCT04367779What this trial is testingResearch of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.Who this might be right forBrain CancerMeningiomaSarcoma Centre Leon Berard 84
Large-scale testing (Phase 3)Looking for participantsNCT05312879What this trial is testingPhase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney DiseaseWho this might be right forProteinuric Kidney Disease Vertex Pharmaceuticals Incorporated 466